ARCHIVES

Women’s Health Trial Committee Hears New Analysis Of Vanguard Groups, Other Data

This article is from The Cancer Letter archive.

Vol. 14 No. 01 | January 1, 1988

Download PDF Visit The Full Archive

Related Articles

FASEB Delivers Its Recommendations For Federal Research Funding in 2013

February 3, 2012

Keytruda Granted Approval In Metastatic Melanoma

September 26, 2014

Price Increase

July 22, 1983

Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment

August 26, 1988

New Group Review First NTP Reports, Gets Job On Permanent Basis, Wrangles Over Extrapolation

July 11, 1980

Lippman Named UCSD Cancer Center Director

May 4, 2012